efavirenz has been researched along with Dyslipidemia in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, L; Li, J; Liu, A; Mahajan, SD; Schwartz, SA; Scott, SR; Shao, Y; Su, B; Sun, L; Wu, H; Ye, J; Yu, H; Zhang, H; Zhang, T | 1 |
| Arpadi, SM; Coovadia, A; Foca, M; Kuhn, L; Liberty, A; Patel, F; Pinillos, F; Ramteke, SM; Shiau, S; Strehlau, R; Violari, A | 1 |
| Aguilar, A; De La Torre, J; Del Arco, A; García-Alegría, J; Olalla, J; Pombo, M; Prada, JL; Ruiz-Mateas, F; Urdiales, D | 1 |
| Casado, JL; Moreno, S | 1 |
| Calmy, A; Cavassini, M; Ciaffi, L; Delhumeau, C; Fehr, J; Genne, D; Hill, A; Hirschel, B; Montecucco, F; Schmid, P; Spycher Elbes, R; Stoeckle, M; Wandeler, G | 1 |
| Bednasz, C; DiFrancesco, R; Feng, Z; Fischl, MA; Gripshover, BM; Gu, J; Luque, AE; Ma, Q; Morse, GD; Venuto, CS; Zingman, BS | 1 |
| Anunnatsiri, S; Chetchotisakd, P; Mootsikapun, P; Thamrongwonglert, P | 1 |
| Bain, AM; Bedimo, R; Busti, AJ; Eaton, SA; Nguyen, ST; Payne, KD; Rahman, AP | 1 |
| Bain, AM; Busti, AJ; Rahman, AP; Rutherford, WS; White, EA | 1 |
| Roca, B | 1 |
| Dubé, MP; Grinspoon, SK; Meyer, WA; Mulligan, K; Parker, RA; Robbins, GK; Roubenoff, R; Shafer, RW; Snyder, SW; Tebas, P; Wininger, DA; Zackin, RA | 1 |
| Aldrovandi, GM; Beretta, S; Giacomet, V; Luraschi, P; Martelli, L; Merlo, M; Mora, S; Rombolà, G; Viganò, A | 1 |
| Curtin, JM; Ward, DJ | 1 |
| Massari, V; Parienti, JJ; Poubeau, P; Rey, D; Verdon, R | 1 |
3 review(s) available for efavirenz and Dyslipidemia
| Article | Year |
|---|---|
[Potential role of rilpivirine in simplification regimens].
Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Clinical Trials as Topic; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Gastrointestinal Diseases; HIV Infections; HIV Protease Inhibitors; Humans; Medication Adherence; Multicenter Studies as Topic; Nitriles; Patient Acceptance of Health Care; Pyrimidines; Reverse Transcriptase Inhibitors; Rilpivirine; Treatment Outcome | 2013 |
A multimodal, evidence-based approach to achieve lipid targets in the treatment of antiretroviral-associated dyslipidemia: case report and review of the literature.
Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Dyslipidemias; Fluorobenzenes; HIV Infections; Humans; Hypolipidemic Agents; Male; Middle Aged; Nevirapine; Patient Compliance; Pyrimidines; Reverse Transcriptase Inhibitors; Rosuvastatin Calcium; Sulfonamides | 2008 |
Pharmacogenomics of antiretrovirals.
Topics: Alkynes; Anti-Retroviral Agents; Aryl Hydrocarbon Hydroxylases; Atazanavir Sulfate; Benzoxazines; Central Nervous System Diseases; Cyclopropanes; Cytochrome P-450 CYP2B6; Dideoxynucleosides; Drug Hypersensitivity; Drug Resistance, Viral; Dyslipidemias; Genetic Predisposition to Disease; Genetic Testing; Glucuronosyltransferase; HLA Antigens; Humans; Hyperbilirubinemia; Nevirapine; Oligopeptides; Oxidoreductases, N-Demethylating; Patents as Topic; Patient Selection; Pharmacogenetics; Pyridines; Ritonavir | 2008 |
4 trial(s) available for efavirenz and Dyslipidemia
| Article | Year |
|---|---|
Switch to etravirine for HIV-positive patients receiving statin treatment: a prospective study.
Topics: Adolescent; Adult; Aged; Alkynes; Benzoxazines; Biomarkers; Cardiovascular Diseases; Cyclopropanes; Drug Substitution; Dyslipidemias; Female; HIV Infections; HIV-1; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Male; Middle Aged; Nitriles; Prospective Studies; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; Young Adult | 2015 |
Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides.
Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Blood Glucose; Cyclopropanes; Drug Therapy, Combination; Dyslipidemias; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Insulin Resistance; Lipids; Male; Nelfinavir; Nucleosides; Oxazines | 2005 |
Improvement in dyslipidaemia after switching stavudine to tenofovir and replacing protease inhibitors with efavirenz in HIV-infected children.
Topics: Adenine; Adolescent; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Child; Cyclopropanes; Dyslipidemias; Female; HIV Infections; HIV-1; Humans; Lipids; Male; Organophosphonates; Oxazines; Protease Inhibitors; Stavudine; Tenofovir; Treatment Outcome; Viral Load | 2005 |
Efavirenz to nevirapine switch in HIV-1-infected patients with dyslipidemia: a randomized, controlled study.
Topics: Alkynes; Benzoxazines; Cholesterol, LDL; Coronary Disease; Cross-Over Studies; Cyclopropanes; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyslipidemias; Female; Follow-Up Studies; HIV Infections; Humans; Male; Nevirapine; Reverse Transcriptase Inhibitors; Severity of Illness Index; Single-Blind Method; Treatment Outcome | 2007 |
7 other study(ies) available for efavirenz and Dyslipidemia
| Article | Year |
|---|---|
Impact of Lopinavir/Ritonavir and Efavirenz-Based Antiretroviral Therapy on the Lipid Profile of Chinese HIV/AIDS Treatment-Naïve Patients in Beijing: A Retrospective Study.
Topics: Adult; Aged; Aged, 80 and over; Alkynes; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Asian People; Beijing; Benzoxazines; Case-Control Studies; Cyclopropanes; Drug-Related Side Effects and Adverse Reactions; Dyslipidemias; Female; HIV Infections; Hospitals, University; Humans; Lipids; Lopinavir; Male; Middle Aged; Retrospective Studies; Ritonavir; Treatment Outcome | 2019 |
Patterns of Growth, Body Composition, and Lipid Profiles in a South African Cohort of Human Immunodeficiency Virus-Infected and Uninfected Children: A Cross-Sectional Study.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Blood Pressure; Body Composition; Child; Child, Preschool; Cross-Sectional Studies; Cyclopropanes; Drug Therapy, Combination; Dyslipidemias; Female; Growth; Growth Disorders; HIV Infections; Humans; Lipids; Longitudinal Studies; Male; Reverse Transcriptase Inhibitors; South Africa | 2018 |
Left ventricular hypertrophy detected by echocardiography in HIV-infected patients.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Carbamates; Comorbidity; Cross-Sectional Studies; Cyclopropanes; Diabetes Mellitus; Drug Combinations; Dyslipidemias; Echocardiography; Female; Furans; HIV Infections; Humans; Hypertension; Hypertrophy, Left Ventricular; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Organophosphates; Organophosphonates; Risk Factors; Ritonavir; Smoking; Spain; Sulfonamides; Tenofovir; Zidovudine | 2013 |
Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders.
Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cyclopropanes; Dyslipidemias; Female; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertriglyceridemia; Hypolipidemic Agents; Lipids; Lipodystrophy; Male; Middle Aged; Retrospective Studies; Substance-Related Disorders | 2016 |
Improvement of lipid profiles when switching from efavirenz to rilpivirine in HIV-infected patients with dyslipidemia.
Topics: Alkynes; Benzoxazines; Cohort Studies; Cyclopropanes; Dyslipidemias; HIV Infections; HIV-1; Humans; Lipids; Rilpivirine; RNA, Viral | 2016 |
Safety and efficacy of simvastatin for the treatment of dyslipidemia in human immunodeficiency virus-infected patients receiving efavirenz-based highly active antiretroviral therapy.
Topics: Aged; Aged, 80 and over; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Cyclopropanes; Dyslipidemias; Female; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Retrospective Studies; Simvastatin; Viral Load | 2008 |
Switch from efavirenz to nevirapine associated with resolution of efavirenz-related neuropsychiatric adverse events and improvement in lipid profiles.
Topics: Adult; Alkynes; Benzoxazines; Cyclopropanes; Dyslipidemias; Female; HIV Infections; Humans; Lipids; Male; Mental Disorders; Middle Aged; Nevirapine; Oxazines; Retrospective Studies; Reverse Transcriptase Inhibitors | 2006 |